Anti-PD-L1 checkpoint inhibitor combined with nanocarrier-mediated cisplatin codelivery system for effective treatment of pancreatic cancer
Article in Molecular Immunology (August 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Molecular Immunology (August 2024)
Article in Frontiers in Oncology (April 2024)
Article in Cancers (April 2024)